D.E. Shaw & Co’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $38.5M | Buy |
|
|||||
|
2025
Q2 | $7.74M | Buy |
|
|||||
|
2025
Q1 | $230K | Sell |
|
|||||
|
2024
Q4 | $392K | Buy |
|
|||||
|
2024
Q3 | $252K | Buy |
|
|||||
|
2024
Q2 | – | Hold |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $529K | Sell |
|
|||||
|
2022
Q3 | $2.89M | Sell |
|
|||||
|
2022
Q2 | $22.1M | Buy |
|
|||||
|
2022
Q1 | $15.9M | Buy |
|
|||||
|
2021
Q4 | $311K | Sell |
|
|||||
|
2021
Q3 | $1.35M | Sell |
|
|||||
|
2021
Q2 | $18.6M | Sell |
|
|||||
|
2021
Q1 | $32.4M | Buy |
|
|||||
|
2020
Q4 | $19.7M | Buy |
|
|||||
|
2020
Q3 | $3.42M | Sell |
|
|||||
|
2020
Q2 | $4.09M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $185K | Buy |
|